全国热线:4001790116,13012892256,17521589219

细胞,培养试剂,生命科学研究整体服务商!

当前位置:首页 > 产品中心(Products) > 细胞定制Cell Customization(Cell Customization) > 原代细胞(Primary Cells) > 人源血液系统(Human Blood System) > 人慢性淋巴细胞白血病pbcd19+/CD5+B细胞-复发/难治

产品中心Products Resources

联系我们CONTACT US

当前位置:首页 > 产品中心(Products) > 细胞定制Cell Customization(Cell Customization) > 原代细胞(Primary Cells) > 人源血液系统(Human Blood System) > 人慢性淋巴细胞白血病pbcd19+/CD5+B细胞-复发/难治
  • 人慢性淋巴细胞白血病pbcd19+/CD5+B细胞-复发/难治

人慢性淋巴细胞白血病pbcd19+/CD5+B细胞-复发/难治

货号:ABC-433

价格: ¥询价

规格:
1 vial
数量: - +
  • 人慢性淋巴细胞白血病pbcd19+/CD5+B细胞-复发/难治
产品描述/Products Description

Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia peripheral blood mononuclear cells using a direct immunomagnetic CD19+ MicroBead labeling system. Available in untreated or relapsed/refractory stages. The co-expression of CD5 is typically found on cancerous Chronic Lymphoid LeukemiaCD19+ B cells. Current research is underway to identify the Chronic Lymphoid Leukemia clonal origin of Chronic Lymphoid Leukemia from this cell population. Although these cells appear mature in morphology, they are in developmental arrest. Researchers have shown that only 1% of these cells are in an active cycle. CD19+/CD5+ B cells play an important role in production of IgM autoantibodies.


For research use only

资料下载
相关产品
×